http://www.zacks.com/stock/news/355926/masimo-and-saudi-arabia-moh-collaborate-for-cchd-screening?cid=CS-ZC-FT-355926
Feb 21, 2019 - Studies have shown that Masimo's (MASI) SET pulse oximetry can improve CCHD screening, helping to save newborns.
zc:-1199842344407618334
0
http://www.zacks.com/stock/news/355505/whats-in-store-for-tandem-diabetes-tndm-q4-earnings?cid=CS-ZC-FT-355505
Feb 20, 2019 - Strong domestic sales along with the launch of the t:slim X2 Insulin Pump in select international markets are likely to drive Tandem Diabetes' (TNDM) Q4 earnings.
zc:-3127713489423043355
0
http://www.zacks.com/stock/news/355192/whats-in-the-cards-for-genomic-health-ghdx-in-q4-earnings?cid=CS-ZC-FT-355192
Feb 18, 2019 - Genomic Health (GHDX) is expected to gain from higher Oncotype DX breast cancer test revenues in Q4.
zc:4572142309879519707
0
http://www.zacks.com/stock/news/353720/whats-in-the-offing-for-davita-dva-this-earnings-season?cid=CS-ZC-FT-353720
Feb 12, 2019 - DaVita (DVA) expects headwinds in DaVita Rx, while overseas prospects of the dialysis business look bright.
zc:226593742600701231
0
http://www.zacks.com/stock/news/353460/can-global-industrial-unit-aid-ecolabs-ecl-q4-earnings?cid=CS-ZC-FT-353460
Feb 11, 2019 - Ecolab's (ECL) preliminary Q4 earnings are likely to fall short of estimates.
zc:3321521846890980926
0
http://www.zacks.com/stock/news/352057/3-medical-instruments-stocks-likely-to-beat-estimates-in-q4?cid=CS-ZC-FT-352057
Feb 05, 2019 - Medical Instruments companies are likely to gain from strong performance in emerging economies and modernization of 510 (k)-clearance pathway by the FDA in Q4.
zc:8909658523069119243
0
http://www.zacks.com/stock/news/351730/whats-in-store-for-cardinal-healths-cah-q2-earnings?cid=CS-ZC-FT-351730
Feb 04, 2019 - Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q2; medical-gloves sub-segment likely to be soft.
zc:-43601065499992527
0
http://www.zacks.com/stock/news/350045/why-masimo-masi-could-beat-earnings-estimates-again?cid=CS-ZC-FT-350045
Jan 28, 2019 - Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:1186019078420862856
0
http://www.zacks.com/stock/news/346716/stock-market-news-for-jan-10-2019?cid=CS-ZC--346716
Jan 10, 2019 - Wall Street rallied for the fourth successive day owing to positive developments on the trade front and Fed Chair???s indication of maintaining caution on further interest rate hikes.
zc:-6896038355524309856
0
http://www.zacks.com/stock/news/346657/masimos-masi-preliminary-results-for-2018-cheer-investors?cid=CS-ZC-FT-346657
Jan 10, 2019 - Masimo (MASI) issues guidance for 2019. It anticipates witnessing strong contribution from its core product revenue segment.
zc:-352268128493140
0